Sonnest, Inc. logo

Sonnest, Inc.

Sonnest, Inc. is pre-clinical healthcare company developing Electrast™, an ultrasound imaging drug that circulates through the body in the inactive state (dark on ultrasound) and is selectively activated (turned on) in the myocardium. With Electrast™ doctors will be able to evaluate perfusion of the heart quickly and cost-effectively at the point of care without exposure to ionizing radiation or toxic dies. The technology was developed by a talented team of cardiologists and chemical engineers at Drexel University with grant funding from the Coulter-Drexel Program and the inventors partnered with a team of successful serial healthcare entrepreneurs who have worked together for over 15 years across multiple companies to form Sonnest.

Free account • No credit card • 5 profiles/day

Medical Equipment Manufacturing 3 Employees Found Baltimore, United States 34273 Similar Companies
3 Employees Found
92% Email Coverage
$727.0K Est Revenue
1 Office HQ
34273 Similar Companies

Frequently asked questions about Sonnest, Inc.

What is Sonnest, Inc. email format?

The widely used Sonnest, Inc. email format is {first_initial}{last} (e.g. jsmith@sonnest.com) with 75.00% adoption across the company.

What is Sonnest, Inc. customer service number?

To contact Sonnest, Inc. customer service number in your country click here to find.

Who are the decision makers in Sonnest, Inc.?

The decision makers in Sonnest, Inc. are Andrew Kohut, Peter Boyd, Josh White, etc. Click to Find Sonnest, Inc. decision makers emails.